---
figid: PMC3303581__JAR2012-251217.001
figtitle: Myostatin signals through the ActRIIB-ALK4/5 heterodimer activate Smad2/3
  with blocking of MyoD transactivation in an autoregulatory feedback loop
organisms:
- Mus musculus
- Rattus norvegicus
- Zea mays
- Malus domestica
- Homo sapiens
- Bos taurus
organisms_ner:
- Rattus norvegicus
- Homo sapiens
- Bos taurus
- Mus musculus
- Drosophila melanogaster
pmcid: PMC3303581
filename: JAR2012-251217.001.jpg
figlink: /pmc/articles/PMC3303581/figure/fig1/
number: F1
caption: Myostatin signals through the ActRIIB-ALK4/5 heterodimer activate Smad2/3
  with blocking of MyoD transactivation in an autoregulatory feedback loop. In addition,
  Smad3 sequesters MyoD in the cytoplasm to prevent it from entering the nucleus and
  activating the stem cell population. Recent findings [, ] have suggested that myostatin-Smad
  pathway inhibits protein synthesis probably due to blocking the functional role
  of Akt. Supplementation with ursolic acid upregulates the amount of IGF-I and insulin
  and then stimulates protein synthesis by activating Akt/mTOR/p70S6K pathway [].
  Treatment with ACE inhibitor also enhances IGF-I level in muscle. Amino acid supplementation
  enhances protein synthesis by stimulating mTOR []. Akt blocks the nuclear translocation
  of FOXO to inhibit the expression of Atrogin-1 and MuRF1 and the consequent protein
  degradation. Proteasome inhibitors combat the ubiquitin-proteasome signaling activated
  by these atrogenes. In cachexic muscle, supplementation with EPA downregulates the
  amount of TNF-α and NF-κB [, ]. Endurance exercise increases the amount of PGC-1α
  through calcineurin- or CaMK-dependent signaling []. Both activated PGC-1α, and
  cyclophilin inhibitor protects several mitochondrial disorders (apoptosis, oxidative
  damage, etc.) elicited by the increase in NF-κB and Bax and/or the decrease in Bcl-2
  in senescent muscle. ACE; angiotensin-converting enzyme, ActRIIB; activin receptor
  IIB, ALK4/5; activin-like kinase 4/5, CaMK; calmodulin kinase, eIF4E; eukaryotic
  initiation factor 4E, EPA; eicosapentaenoic acid, FOXO; Forkhead box O, IGF-I; insulin-like
  growth factor-I, IKK; inhibitor of κB kinase, mTOR; mammalian target of rapamycin,
  MuRF1; muscle ring-finger protein 1, NF-κB; nuclear factor of kappa B, PGC-1α; peroxisome
  proliferator-activated receptor γ coactivator α, PI3-K; phosphatidylinositol 3-kinase,
  Rheb; Ras homolog enriched in brain, TNF-α; tumor nectosis factor-α, TORC1; a component
  of TOR-signaling complex 1.
papertitle: Novel Intriguing Strategies Attenuating to Sarcopenia.
reftext: Kunihiro Sakuma, et al. J Aging Res. 2012;2012:251217.
year: '2012'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.944156
figid_alias: PMC3303581__F1
figtype: Figure
redirect_from: /figures/PMC3303581__F1
ndex: ee072109-df00-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3303581__JAR2012-251217.001.html
  '@type': Dataset
  description: Myostatin signals through the ActRIIB-ALK4/5 heterodimer activate Smad2/3
    with blocking of MyoD transactivation in an autoregulatory feedback loop. In addition,
    Smad3 sequesters MyoD in the cytoplasm to prevent it from entering the nucleus
    and activating the stem cell population. Recent findings [, ] have suggested that
    myostatin-Smad pathway inhibits protein synthesis probably due to blocking the
    functional role of Akt. Supplementation with ursolic acid upregulates the amount
    of IGF-I and insulin and then stimulates protein synthesis by activating Akt/mTOR/p70S6K
    pathway []. Treatment with ACE inhibitor also enhances IGF-I level in muscle.
    Amino acid supplementation enhances protein synthesis by stimulating mTOR [].
    Akt blocks the nuclear translocation of FOXO to inhibit the expression of Atrogin-1
    and MuRF1 and the consequent protein degradation. Proteasome inhibitors combat
    the ubiquitin-proteasome signaling activated by these atrogenes. In cachexic muscle,
    supplementation with EPA downregulates the amount of TNF-α and NF-κB [, ]. Endurance
    exercise increases the amount of PGC-1α through calcineurin- or CaMK-dependent
    signaling []. Both activated PGC-1α, and cyclophilin inhibitor protects several
    mitochondrial disorders (apoptosis, oxidative damage, etc.) elicited by the increase
    in NF-κB and Bax and/or the decrease in Bcl-2 in senescent muscle. ACE; angiotensin-converting
    enzyme, ActRIIB; activin receptor IIB, ALK4/5; activin-like kinase 4/5, CaMK;
    calmodulin kinase, eIF4E; eukaryotic initiation factor 4E, EPA; eicosapentaenoic
    acid, FOXO; Forkhead box O, IGF-I; insulin-like growth factor-I, IKK; inhibitor
    of κB kinase, mTOR; mammalian target of rapamycin, MuRF1; muscle ring-finger protein
    1, NF-κB; nuclear factor of kappa B, PGC-1α; peroxisome proliferator-activated
    receptor γ coactivator α, PI3-K; phosphatidylinositol 3-kinase, Rheb; Ras homolog
    enriched in brain, TNF-α; tumor nectosis factor-α, TORC1; a component of TOR-signaling
    complex 1.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Tnf
  - Ace
  - Igf1
  - Pik3cg
  - Smad2
  - Smad3
  - Akt1
  - Rheb
  - Mtor
  - Fbxo32
  - Eif4e
  - TNF
  - TIMP1
  - ACE
  - IGF1
  - CAMK4
  - CAMK2G
  - CAMK1
  - CAMK1D
  - CAMK1G
  - CAMK2A
  - CAMK2B
  - CAMK2D
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - SMAD2
  - SMAD3
  - AKT1
  - AKT2
  - AKT3
  - MYOD1
  - CHUK
  - IKBKB
  - IKBKG
  - IKBKE
  - TBK1
  - PPARGC1A
  - RHEB
  - RHEBP1
  - FOXO1
  - FOXO3
  - FOXO4
  - FOXO6
  - RPS6KB1
  - RPS6KB2
  - MTOR
  - EIF4E
  - CWC27
  - PPIA
  - PPIB
  - PPIC
  - PPID
  - PPIE
  - PPIF
  - PPIH
  - PPIL1
  - PPIL2
  - PPIL3
  - PPIL4
  - PPIL6
  - PPWD1
  - PPIAL4A
  - PPIAL4C
  - PPIAL4G
  - PSMA1
  - PSMA2
  - PSMA3
  - PSMA4
  - PSMA5
  - PSMA6
  - PSMA7
  - PSMA8
  - PSMB1
  - PSMB10
  - PSMB2
  - PSMB3
  - PSMB4
  - PSMB5
  - PSMB6
  - PSMB7
  - PSMB8
  - PSMB9
  - PSMC1
  - PSMC2
  - PSMC3
  - PSMC4
  - PSMC5
  - PSMC6
  - PSMD1
  - PSMD10
  - PSMD11
  - PSMD12
  - PSMD13
  - PSMD14
  - PSMD2
  - PSMD3
  - PSMD4
  - PSMD5
  - PSMD6
  - PSMD7
  - PSMD8
  - PSMD9
  - PSME1
  - PSME2
  - PSME3
  - PSMF1
  - SEM1
  - USP5
  - ACVR2B
  - ACVR1B
  - Timp1
  - Camk1
  - Pik3r1
  - Myod1
  - Ppargc1a
  - Rps6kb1
  - Acvr2b
  - Acvr1b
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - egr
  - Pka-R2
  - mab
  - Acer
  - Ance
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Smox
  - Akt
  - nau
  - IKKepsilon
  - key
  - IKKbeta
  - srl
  - foxo
  - S6k
  - Tor
  - eIF4E1
  - Ursolic acid
  - Cancer
---
